Quick Answer
NextCure, Inc. reported Operating Income of -$57.62 million for fiscal year 2025.
NextCure, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$57.62M | +3.6% |
| 2024 | -$59.75M | +11.7% |
| 2023 | -$67.64M | +10.9% |
| 2022 | -$75.91M | -7.3% |
| 2021 | -$70.77M | -71.7% |
| 2020 | -$41.23M | -10.0% |
| 2019 | -$37.48M | -61.6% |
| 2018 | -$23.20M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$8.95M | +28.4% | +67.2% |
| June 30, 2025 | -$27.29M | -65.5% | -134.8% |
| March 31, 2025 | -$11.62M | +36.5% | +7.0% |
| September 30, 2024 | -$12.49M | +20.0% | +24.2% |
| June 30, 2024 | -$16.49M | +13.9% | +9.9% |
| March 31, 2024 | -$18.30M | -7.2% | -17.2% |
| September 30, 2023 | -$15.62M | +18.8% | +18.5% |
| June 30, 2023 | -$19.16M | -5.7% | -12.2% |
- NextCure, Inc. showed an increase of +3.6% in Operating Income compared to the prior fiscal year.
- Over the 2018–2025 period, NextCure, Inc.’s operating income has declined by 148.4% (from -$23.20 million to -$57.62 million).
- The most recent figure is from NextCure, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: